Some useful confirmatory data on the prevalence of BE according to status of various risk factors.
A thoughtful commentary on the strengths and weakness of the recent clinical trial of PPI and aspirin.
In this cross-sectional study of patients seen at Mayo Clinic between 2002 and 2010, use of smokeless tobacco and cigars or pipes was found to be associated with risk of Barrett’s in persons with GERD. Confirmatory studies are needed.
Dr. Michael Cook and colleagues at NCI report that certain markers of inflammation in blood are associated with esophageal adenocarcinoma, and conclude that systemic inflammation may underlie some of the increased risk with obesity and cigarette smoking.
Investigators from Queen Mary University of London examine past trends in esophageal cancer incidence and project a leveling off in rates of esophageal adenocarcinoma over the next two decades.
Investigators from Thomas Jefferson University estimate more than a five-fold increased risk of developing esophageal adenocarcinoma in persons with Barrett's who have a first-degree relative with Barrett's.